Clinical Trials Browser

OTHER × Smoldering Multiple Myeloma × elotuzumab × Clear all

NCT02279394 2023-06-09

E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Phase 2 Completed

51 enrolled 14 charts

Smoldering Multiple Myeloma